Hamilton General Hospital
Hamilton, Ontario, L8L2X2, Canada
NCT Number: NCT01740479
To determine whether, on a background of optimal medical therapy, including ticagrelor, opening of all suitable narrowings or blockages found at the time of primary PCI for an acute heart attack is better than treating only the culprit lesion in patients with multi-vessel disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hamilton, Ontario, L8L2X2, Canada
To determine if a strategy of multivessel revascularization involving PCI of all suitable non-infarct related artery lesions plus optimal medical therapy is superior to a strategy of optimal medical therapy alone in reducing (1) the composite outcome of cardiovascular (CV) death or new myocardial infarction (MI), or (2) the composite of CV death, new MI or ischemia driven revascularization (IDR) in patients with multivessel disease who have undergone early successful culprit lesion PCI for STEMI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Staged PCI using second generation drug eluting stents (Promus Element Plus drug-eluting stent or newer version in this series is strongly recommended) of all suitable non-culprit lesions plus optimal medical therapy.
Other names: Staged Non-Culprit Lesion PCI plus Optimal Medical Therapy
Time frame: over duration of follow-up (average of approximately 4 years)
Co-primary outcome: CV death or new MI
Time frame: over duration of follow-up (average of approximately 4 years)
Co-primary outcome: CV death, new MI or IDR
Time frame: Over duration of follow-up (average of approximately 4 years)
Time frame: Over duration of follow-up (average of approximately 4 years)
Population Health Research Institute
Other
Randomized Comparative Effectiveness Study of Complete vs Culprit-only Revascularization Strategies to Treat Multi-vessel Disease After Early Percutaneous Coronary Intervention (PCI) for ST-segment Elevation Myocardial (STEMI) Infarction
Acronym: COMPLETE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02926755
Acute Myocardial Infarction, Arterial Occlusive Diseases
Royal Oak, Michigan, United States
View Trial DetailsNCT05701358
Acute Myocardial Infarction, Arterial Occlusive Diseases
Los Angeles, California, United States
View Trial DetailsNCT03834155
Acute Myocardial Infarction, Angina Pectoris
Denver, Colorado, United States
View Trial DetailsNCT06468982
Acute Myocardial Infarction, Arterial Occlusive Diseases
Yakutiye, Erzurum, Turkey (Türkiye)
View Trial Details